13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51.
University Of Illinois At Chicago
Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.
Pfizer
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity.
University Of Chicago
Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptide.
Centre National De La Recherche Scientifique & Universite De Nantes
Inhibition of homologous recombination in human cells by targeting RAD51 recombinase.
Drexel University College Of Medicine
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
University Of Bologna
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib.
Istituto Italiano Di Tecnologia
Styryl quinazolinones and its ethynyl derivatives induce myeloid differentiation.
National University Of Singapore
